BackAmplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Overview

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Gross Profit

Gross Profit analysis for GERM.

Quarterly Gross Profit

N/A

As of Mar 31, 2026

Annual Gross Profit (TTM)

$308.63M
↓ 55.85% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin